Bio Pharma Dive
JUNE 2, 2021
Royalty Pharma will effectively fund MorphoSys' acquisition of the cancer biotech through a separate agreement to buy MorphoSys' shares of royalties on several marketed and experimental medicines.
World of DTC Marketing
JUNE 2, 2021
SUMMARY: Doctors said they were dissatisfied were marketing emails (46%), telephone sales calls with sales reps (42%), and both webinars and websites (each at 39%) from pharma companies, according to Indegene. That should, however, not discourage the use of email to HCPs. If you follow some basic testing, email can be an effective tool for communicating information. 100 percent of U.S. pharma marketers use email marketing, and research shows that 73 percent of in-house marketers believe email m
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Pharma Mirror
JUNE 2, 2021
Increasing instances of substandard, falsified and counterfeit medical products continue to pose a major challenge to the global healthcare system which is already suffering from the dire impact of COVID-19. To address this issue, ASPA and Messe Frankfurt India will unite leading experts from the pharmaceutical segment for a live panel discussion on 11 June 2021.
Pharma Times
JUNE 2, 2021
Updated study results showed an overall response rate of 98% with a longer-term follow-up at a median of 18 months
Advertisement
Planning on running clinical trials in Japan? How can you reliably supply these studies? Discover Catalent’s clinical supply packaging facility in Shiga, Japan. Strategically located between Tokyo and Osaka, and one of largest in Japan, this 6,000 square meter facility offers comprehensive services including primary and secondary clinical packaging and labelling, comparator sourcing, cold chain storage, local and global distribution, local language support and white glove service to support stud
pharmaphorum
JUNE 2, 2021
In the latest edition of What HCPs Think , CREATION.co’s Laura Marsh looks at what healthcare professionals are saying about blood clots linked to COVID-19 vaccines. The formation of blood clots is a necessary process in order for the body to repair damage caused by injury and to slow down bleeding. However, when blood clots form inappropriately, this limits blood flow through vessels and can pose a significant health risk.
BioSpace
JUNE 2, 2021
Migraine headaches can be reduced in frequency and severity by atogepant, an oral therapy developed by AbbVie, according to data presented at the American Headache Society’s (AHS) Annual Scientific Meeting.
Clinical Research Informer brings together the best content for clinical researchers from the widest variety of industry thought leaders.
BioSpace
JUNE 2, 2021
The nation’s top science adviser believes the country’s renewed enthusiasm for science may pave the way for plug-and-play vaccines that can nullify the next pandemic before it starts.
Scienmag
JUNE 2, 2021
New technology captures never-before-heard sounds of lynx hunting, fighting, and sleeping Credit: Emily Studd Using a Fitbit and a spy mic, scientists have discovered new insight into the behaviour of the elusive Canada lynx. A new study by researchers from McGill University, University of Alberta, and Trent University provides a first look at how miniaturized […].
BioSpace
JUNE 2, 2021
Shares of Protagonist Therapeutics climbed nearly 4% in premarket trading after the company announced its lead drug candidate rusfertide snagged Breakthrough Therapy Designation from the U.S. FDA.
FDA Law Blog
JUNE 2, 2021
By Ricardo Carvajal & Karin F.R. Moore & JP Ellison — As has been widely covered in local and national press in and around the Washington, DC area, this month marks the once every seventeen year emergence of the Brood X cicadas. These insects are so plentiful in local areas with trees, including FDA’s aptly named White Oak campus, that they have prompted lots of advice about whether it is safe for human and pets to consume them.
Advertisement
White paper that delves into the complex topic of Decentralized Clinical Trials and how to master them within the confines of FDA Regulations
Scienmag
JUNE 2, 2021
New research paves the way to hyper-efficient data storage Credit: TU Delft Atomically thin van der Waals magnets are widely seen as the ultimately compact media for future magnetic data storage and fast data processing. Controlling the magnetic state of these materials in real-time, however, has proven difficult. But now, an international team of researchers […].
XTalks
JUNE 2, 2021
The US Food and Drug Administration (FDA) has granted approval to Amgen’s KRAS inhibitor Lumakras (sotorasib) as the first treatment for non-small cell lung cancer (NSCLC) harboring the KRAS G12C mutation. KRAS mutations have previously been considered ‘undruggable’ targets, but they have been a big focus in cancer research as they are one of the most common gene mutations across all cancers.
Scienmag
JUNE 2, 2021
Credit: University of Illinois URBANA, Ill. -When pigs get hit with significant illnesses during key stages of pregnancy, their immune response may negatively affect developing piglets, making them less productive on the farm. New research from the University of Illinois shows that when those piglets – especially males – experience a second stressor in early […].
BioSpace
JUNE 2, 2021
AbbVie has been the target of multiple legal inquiries and challenges of its pricing and patent protections. Now, a U.S. senator is taking a gander at the company’s taxes.
Advertisement
When selecting a clinical supply provider, consideration often focuses upon the manufacturing, packaging, storage and distribution capabilities available that will, at face-value, be sufficient to meet the needs of the sponsor and their trial. However, there are human-based and knowledge-driven factors that are often overlooked that go beyond these basic physical capabilities and are integral to the development and delivery of high performing clinical supply chains.
Scienmag
JUNE 2, 2021
Credit: Singapore Management University SMU Office of Research & Tech Transfer – In 2015, Singapore Management University (SMU) introduced an innovative university-wide pedagogical experiential learning programme called SMU-X. The programme expanded quickly. From a pilot initiative with two courses offered by a small team of enthusiastic faculty and taken by 58 students, it grew to […].
BioSpace
JUNE 2, 2021
Today, the Swiss pharma titan announced the results of its Phase III VISION study, where 177Lu-PSMA-617 plus best standard of care (SOC) met both of its primary endpoints.
Scienmag
JUNE 2, 2021
Researchers create novel CRISPR-based fly species as a new method of controlling gene drive spread Credit: Akbari lab, UC San Diego CRISPR-based technologies offer enormous potential to benefit human health and safety, from disease eradication to fortified food supplies. As one example, CRISPR-based gene drives, which are engineered to spread specific traits through targeted populations, […].
Pharma Times
JUNE 2, 2021
A WHO emergency use listing (EUL) is issued when a product meets international standards for safety, efficacy and manufacturing
Advertisement
This new white paper defines and details the impact of Decentralized Clinical Trials on the Pharmaceutical industry and how the impact can be measured along with steps companies can take to ensure adoption.
Scienmag
JUNE 2, 2021
Texas A&M associate professor Akhilesh Gaharwar and graduate student Patrick Lee are developing a new class of hydrogels that can leverage light for drug delivery and regenerative medicine treatments. Credit: Texas A&M Engineering Hydrogels are commonly used inside the body to help in tissue regeneration and drug delivery. However, once inside, they can be challenging […].
BioPharma Reporter
JUNE 2, 2021
June 2021 marks the 40th anniversary of the publication of the first reported cases of AIDS in the US. A session at BIO Digital â featuring Dr. Anthony Fauci, Director of NIAID at the US NIH â will focus on four decades of innovation as well as the critical importance of collaboration and investment moving forward.
Scienmag
JUNE 2, 2021
Credit: Dr. Orla Bath Enright A large group of iconic fossils widely believed to shed light on the origins of many of Earth’s animals and the communities they lived in may be hiding a secret. Scientists, led by two from the University of Portsmouth, UK, are the first to model how exceptionally well preserved fossils […].
BioPharma Reporter
JUNE 2, 2021
A robust research and innovation ecosystem makes Italy an attractive life sciences hotspot, according to a post from an Italian trade delegation at Bio Digital 2021.
Advertisement
As the development pipeline for new drugs continues to grow, biopharmaceutical companies are re-evaluating how to best manage and balance resources across an increasing number of development projects and complex clinical trials. There are two approaches that can be used to speed a drug from development to clinic faster: timeline compression and parallel processing, but only one that considers the benefits of integrating clinical supply into the overall drug development process.
Scienmag
JUNE 2, 2021
Credit: Singapore Management University SMU Office of Research & Tech Transfer – The latest figures from Singapore’s Ministry of Education (MOE) show that females now represent 41 percent of the total STEM (Science, Technology, Engineering, and Mathematics) cohort at the country’s six autonomous universities. Even though this is a promising trend for STEM, only slightly […].
pharmaphorum
JUNE 2, 2021
The first batch of EU countries have started recognising the vaccination status of travellers using digital vaccine certificates as the bloc moves towards freeing up travel ahead of the summer period. Germany, Greece, Bulgaria, Czech Republic, Denmark, Croatia and Poland are the first to start using the scheme, which will allow people who have been fully vaccinated against COVID-19, tested negative recently, or recovered from the disease to travel without restriction within the EU.
Scienmag
JUNE 2, 2021
Credit: Cincinnati Children’s A study published in the journal Pediatrics shows the combination of two early reading programs had positive effects on preschool students entering kindergarten in Cincinnati Public Schools over a three-year period. The two early reading programs are: Reach Out and Read, through which children receive a new book and guidance about reading […].
BioSpace
JUNE 2, 2021
Organon’s focus will center on reproductive health, health conditions, and issues unique to women and diseases that disproportionately impact women.
Advertisement
Clinical trial data management is increasingly challenging as studies grow in complexity. Quickly accessing and analyzing study data is vital for assessing trial progress and patient safety. In this paper, we explore real-time data access and analysis for proactive study management. We investigate using adverse event (AE) data to monitor safety and discuss a clinical analytics platform that supports collaboration and data review workflows.
Scienmag
JUNE 2, 2021
Credit: Photo by L. Brian Stauffer CHAMPAIGN, Ill. — Many species of ground-dwelling beetles, ladybugs, hoverflies, damsel bugs, spiders and parasitic wasps kill and eat pest species that routinely plague farmers, including aphids and corn rootworm larvae and adults. But the beneficial arthropods that live in or near cropped lands also are susceptible to insecticides […].
BioSpace
JUNE 2, 2021
venBio Global Strategic Fund IV will invest primarily in drug companies focused on developing therapies for unmet medical needs.
Scienmag
JUNE 2, 2021
ITHACA, N.Y. – All fish are not created equal, at least when it comes to nutritional benefits. This truth has important implications for how declining fish biodiversity can affect human nutrition, according to a computer modeling study led by Cornell and Columbia University researchers. The study, “Declining Diversity of Wild-Caught Species Puts Dietary Nutrient Supplies […].
BioSpace
JUNE 2, 2021
Venture capitalist Chamath Palihapitiya is raising $800 million to finance four more special purpose acquisition companies that will be focused on taking biotech companies public.
Advertisement
The global landscape of clinical trials is rapidly changing as studies become more complex. An increasing number of sponsors are seeking enhanced flexibility in their supply chains to address a variety of clinical supply challenges, including patient demand and reducing delays. Demand-led supply and direct-to-patient distribution are next-generation solutions that are helping to meet these growing needs, allowing for more streamlined processes and patient-centric studies.
Expert insights. Personalized for you.
301 
Let's personalize your content